Targeting colorectal cancer stem-like cells: Overcoming therapeutic resistance and reprogramming the immunosuppressive niche
Cancer Letters · 2026-09 · 656 · 218665
DOI: 10.1016/j.canlet.2026.218665 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2026-09. Verfasst von Mahasin Hamid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Faculty of Sciences and Information Technology, University of Nyala, Nyala, 63311, Sudan; School of Health Sciences, Universit…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Colorectal Neoplasms, Tumor Microenvironment, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 267 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universiti Sains Malaysia.
Abstract (Originalsprache)
Colorectal cancer stem-like cells (CRC-SCs) represent a tumor subpopulation with enhanced tumor-initiating capacity and have been implicated in metastasis, therapeutic resistance, and disease relapse. These cells not only possess intrinsic resistance mechanisms, such as quiescence, enhanced DNA repair, and ABC transporter overexpression, but also actively orchestrate a profoundly immunosuppressive tumor microenvironment (TME). Emerging evidence suggests that CRC-SCs may contribute to shaping an immunosuppressive TME through secretion of exosomes and cytokines that influence immune cells (e.g., regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages) and key stromal cell populations (e.g., cancer-associated fibroblasts). This review provides a comprehensive analysis of the evolving landscape of immunotherapies designed to target CRC-SCs. We evaluate immunotherapeutic strategies including immune checkpoint inhibitors, while also discussing the targeting of critical signaling pathways like Wnt, Notch, and Hh. Furthermore, we explore the growing role of artificial intelligence (AI)-based approaches in deciphering CRC-SC heterogeneity, identifying predictive biomarkers, and accelerating therapeutic target discovery. Despite these advancements, significant challenges remain, including tumor heterogeneity, the immunosuppressive TME, and on-target/off-tumor toxicity. We conclude by outlining future directions that emphasize combination therapies, novel delivery systems, and AI-driven precision medicine as crucial strategies to more effectively target CRC-SC populations and improve durable disease control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Zoology, Faculty of Sciences and Information Technology, University of Nyala, Nyala, 63311, Sudan; School of Health Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, 16150, Malaysia.
- Electronics Engineering Department, Faculty of Engineering and Technology, University of Gezira, Sudan.
- School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
- UPMC Hillman Cancer Center, Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15224, USA.
- Department of Hematology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, 16150, Malaysia; Department of Biology, Faculty of Education, Omdurman Islamic University, P.O. Box 382, Omdurman…
- UPMC Hillman Cancer Center, Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15224, USA. Electronic address: maa879@pitt.edu.
Förderung
- Universiti Sains Malaysia
Zitieren
APA
Hamid, M., Siddig, A. M. A., Suliman, R., Saeed, A., Mussa, A., & Al-Hatamleh, M. A. I. (2026). Targeting colorectal cancer stem-like cells: Overcoming therapeutic resistance and reprogramming the immunosuppressive niche. Cancer Letters, 656, 218665. https://doi.org/10.1016/j.canlet.2026.218665
Vancouver
Hamid M, Siddig AMA, Suliman R, Saeed A, Mussa A, Al-Hatamleh MAI. Targeting colorectal cancer stem-like cells: Overcoming therapeutic resistance and reprogramming the immunosuppressive niche. Cancer Letters. 2026;656:218665. doi:10.1016/j.canlet.2026.218665
BibTeX
@article{Hamid2026,
author = {Hamid, Mahasin and Siddig, Alia M A and Suliman, Ruaa and Saeed, Anwaar and Mussa, Ali and Al-Hatamleh, Mohammad A I},
title = {Targeting colorectal cancer stem-like cells: Overcoming therapeutic resistance and reprogramming the immunosuppressive niche},
journal = {Cancer Letters},
year = {2026},
volume = {656},
pages = {218665},
doi = {10.1016/j.canlet.2026.218665}
}
EUVIMED